Cargando…
Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname
Convalescent plasma is a promising therapy for coronavirus disease 2019 (COVID-19), but its efficacy in intensive care unit (ICU) patients in low- and middle-income country settings such as Suriname is unknown. Bedside plasma separation using the HemoClear device made convalescent plasma therapy acc...
Autores principales: | Bihariesingh-Sanchit, R., Bansie, R., Ramdhani, N., Mangroo, R., Bustamente, D., Diaz, E., Fung A Foek, C., Thakoer, I., Vreden, S., Choudhry, Z., van ‘t Wout, A. B., Diavatopoulos, D. A., Nierich, A. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127603/ https://www.ncbi.nlm.nih.gov/pubmed/36815780 http://dx.doi.org/10.1128/mbio.03379-22 |
Ejemplares similares
-
An In Vitro Pilot Study Comparing the Novel HemoClear Gravity-Driven Microfiltration Cell Salvage System with the Conventional Centrifugal XTRA™ Autotransfusion Device
por: Hoetink, Anneloes, et al.
Publicado: (2020) -
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
por: Vreden, Stephen GS, et al.
Publicado: (2016) -
Evidence of an increased incidence of day 3 parasitaemia in
Suriname: an indicator of the emerging resistance of Plasmodium
falciparum to artemether
por: Vreden, Stephen GS, et al.
Publicado: (2013) -
Gold mining areas in Suriname: reservoirs of malaria resistance?
por: Adhin, Malti R, et al.
Publicado: (2014) -
Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname
por: Adhin, Malti R, et al.
Publicado: (2012)